The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells
Top Cited Papers
- 1 January 2006
- Vol. 49 (1) , 67-79
- https://doi.org/10.1016/j.neuron.2005.11.027
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Emerging properties of cannabinoid medicines in management of multiple sclerosisTrends in Neurosciences, 2005
- Endocannabinoids Mediate Rapid Retrograde Signaling At Interneuron → Pyramidal Neuron Synapses of the NeocortexJournal of Neurophysiology, 2003
- Transcriptional Induction of MKP-1 in Response to Stress Is Associated with Histone H3 Phosphorylation-AcetylationMolecular and Cellular Biology, 2001
- Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1Nature Cell Biology, 2001
- Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegenerationJournal of Neurochemistry, 2001
- Translating the Histone CodeScience, 2001
- Contribution of Microglia/Macrophages to Expansion of Infarction and Response of Oligodendrocytes After Focal Cerebral Ischemia in RatsStroke, 2000
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamideFEBS Letters, 1995
- Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compoundsLife Sciences, 1984